Orgenesis Inc (ORGS)
0.5701
+0.02
(+2.91%)
USD |
NASDAQ |
May 10, 16:00
0.5701
0.00 (0.00%)
After-Hours: 19:19
Orgenesis Revenue (TTM): 0.53M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.53M |
| September 30, 2023 | 13.99M |
| June 30, 2023 | 21.87M |
| March 31, 2023 | 28.96M |
| December 31, 2022 | 36.02M |
| September 30, 2022 | 29.29M |
| June 30, 2022 | 29.98M |
| March 31, 2022 | 33.32M |
| December 31, 2021 | 35.50M |
| September 30, 2021 | 30.91M |
| June 30, 2021 | 23.96M |
| March 31, 2021 | 15.16M |
| December 31, 2020 | 7.652M |
| September 30, 2020 | -14.92M |
| June 30, 2020 | -7.532M |
| March 31, 2020 | -8.15M |
| Date | Value |
|---|---|
| December 31, 2019 | -2.727M |
| September 30, 2019 | 23.36M |
| June 30, 2019 | 20.46M |
| March 31, 2019 | 23.32M |
| November 30, 2018 | 18.66M |
| August 31, 2018 | 16.23M |
| May 31, 2018 | 12.56M |
| February 28, 2018 | 10.87M |
| November 30, 2017 | 10.09M |
| August 31, 2017 | 8.608M |
| May 31, 2017 | 7.895M |
| February 28, 2017 | 6.729M |
| November 30, 2016 | 6.397M |
| August 31, 2016 | 5.718M |
| May 31, 2016 | 4.806M |
| February 29, 2016 | 4.494M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
-14.92M
Minimum
Sep 2020
36.02M
Maximum
Dec 2022
16.72M
Average
21.87M
Median
Jun 2023
Revenue (TTM) Benchmarks
| Altimmune Inc | 0.426M |
| Verastem Inc | -- |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Dare Bioscience Inc | -- |